Active	Status	Sponsor type	Region	Phase	Filter
1 Active 9 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
List, Alan F
NCT03826082: PRGN-3006 Adoptive Cellular Therapy Relapsed or Refractory CD33-Positive AML or High Risk MDS	Not yet recruiting	1	56	US	PRGN-3600 T Cells	H. Lee Moffitt Cancer Center and Research Institute	Myelodysplastic Syndromes, Acute Myeloid Leukemia	04/22	04/35
Saba, Hussain I
No trials found